CFDE Data Portal | Search LRRC19

	Label	Description
	LRRC19 associations Collection (Entity type)	Associations for LRRC19_associations
	LRRC19 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LRRC19 Gene (Entity type)	ENSG00000184434 - leucine rich repeat containing 19
	GSE210655 1 V 0 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 6 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE157904 3 V 1 DOXORUBICIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 6 V 11 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 1 V 6 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE110178 1 V 7 TRANYLCYPROMINE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

LRRC19 associations

Associations for LRRC19_associations

LRRC19 associations.tsv

A file from IDG as part of the Harmonizome project

LRRC19

ENSG00000184434 - leucine rich repeat containing 19

GSE210655 1 V 0 CISPLATIN MOUSE UP

A Gene Set from LINCS

GSE233679 nicotinamide 6 v 11 human dn

A Gene Set from LINCS

GSE157904 3 V 1 DOXORUBICIN MOUSE DN

A Gene Set from LINCS

GSE233679 6 V 11 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE210655 1 V 6 CISPLATIN MOUSE UP

A Gene Set from LINCS

GSE218060 decitabine T cell 7 v 0 human dn

A Gene Set from LINCS

GSE110178 1 V 7 TRANYLCYPROMINE MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.